CDKL5 and craniodiaphyseal dysplasia: Notably, neuroanatomical changes induced by the anti-inflammatory treatment with luteolin were associated with an improvement in behavioral performance in Cdkl5 KO mice, strengthening the prospect that CDD patients could benefit from anti-inflammatory treatments.